 safeti toler oral dextromethorphan patient risk brain ischemia experiment ischemia model antituss dextromethorphan n-methyl-d-aspart antagonist neuroprotect properti patient histori recent stroke transient ischem attack oral dextromethorphan mg q.i.d week placebo-control double-blind crossov toler studi clinic evid toxic attribut preliminari studi